The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition
Open accessAbstract
Amyloid-β (Aβ) plaque deposition can precede the clinical manifestations of dementia of the Alzheimer type (DAT) by many years and can be associated with changes in brain metabolism. Both the Aβ plaque deposition and the changes in metabolism appear to be concentrated in the brain's default-mode network. In contrast to prior studies of brain metabolism which viewed brain metabolism from a unitary perspective that equated glucose utilization with oxygen consumption, we here report on regional glucose use apart from that entering oxidative phosphorylation (so-called "aerobic glycolysis"). Using PET, we found that the spatial distribution of aerobic glycolysis in normal young adults correlates spatially with Aβ deposition in individuals with DAT and cognitively normal participants with elevated Aβ, suggesting a possible link between regional aerobic glycolysis in young adulthood and later development of Alzheimer pathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, brain AG was previously found to be highest in regions most vulnerable to amyloid deposition”
From Aerobic glycolysis in the human brain is associated with development and neotenous gene expression (2014) · cites this paper as Vlassenko et al., 2010
In the citing paper
“Further, AG identifies regions most vulnerable to amyloid-beta deposition in Alzheimer’s disease”
From Aerobic glycolysis in the human brain is associated with development and neotenous gene expression (2014) · cites this paper as Vlassenko et al., 2010
In the citing paper
“Young ApoE4 carriers showed increased brain activity in default network regions, as well as in the hippocampus and the temporal lobe, possibly due to increased aerobic glycolysis.34”
From ApoE4-dependent lysosomal cholesterol accumulation impairs mitochondrial homeostasis and oxidative phosphorylation in human astrocytes (2023) · cites this paper as [34]
In the citing paper
“Whether Aβ changes precede either age-related or AD-related brain bioenergetic changes is less clear-cut, especially since abundant data from human and cell-based studies either suggest or demonstrate bioenergetic factors regulate both APP processing and Aβ production [95–100].”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [99]
In the citing paper
“Whether Aβ changes precede either age-related or AD-related brain bioenergetic changes is less clear-cut, especially since abundant data from human and cell-based studies either suggest or demonstrate bioenergetic factors regulate both APP processing and Aβ production [95–100].”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [99]
In the citing paper
“Brain plaque deposition anatomically corresponds to the functional magnetic resonance imaging (fMRI)-defined default mode network (DMN), a brain region characterized by relatively high glycolysis rates [69, 99, 136].”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [99]
In the citing paper
“Bioenergetic metabolism certainly affects APP processing and Aβ production.”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [99]
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
A default mode of brain function
Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.676 · Cited by 12,190
Self-citationThe Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citationThe Brain's Default Network: Anatomy, Function, and Relevance to Disease
Buckner, R. L., Andrews‐Hanna, J. R., & Schacter, D. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1440.011 · Cited by 9,761
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Pellerin, L., & Magistretti, P. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10625 · Cited by 2,927 · cited 1×
“First, it is essential for the removal of glutamate into astrocytes from the synaptic cleft (40).”
BackgroundPhelps, M. E., Huang, S. C., Hoffman, E. J., Selin, C. E., Sokoloff, L., & Kuhl, D. E. (1979) · Annals of Neurology · doi:10.1002/ana.410060502 · Cited by 2,417
A default mode of brain function: a brief history of an evolving idea
Raichle, M. E., & Snyder, A. Z. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.02.041 · Cited by 2,173
Self-citation
Cited by
Sorted by citations
Items 301–400 of 405
Scale-spanning crosstalk between metabolism and information processing
Barros, L. F., Fernández‐Moncada, I., Marsicano, G., Ruminot, I., Saab, A. S., & Weber, B. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.10.012 · Cited by 8
Inverse correlation between Alzheimer’s disease and cancer from the perspective of hypoxia
Su, Z., Zhang, G., Li, X., & Zhang, H. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.07.002 · Cited by 7
Malaquin, S., Lerchundi, R., Mougel, E., & Valette, J. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2403635121 · Cited by 7
Potential Roles of α-amylase in Alzheimer’s Disease: Biomarker and Drug Target
Chen, W. N., Tang, K. S., & Yeong, K. Y. (2021) · Current Neuropharmacology · doi:10.2174/1570159x20666211223124715 · Cited by 7
Inhibition of chaperonin GroEL by a monomer of ovine prion protein and its oligomeric forms
Kudryavtseva, S. S., Stroylova, Y. Y., Zanyatkin, I. A., Haertlé, T., & Muronetz, V. I. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916100199 · Cited by 7
Taming Alzheimer's disease: New perspectives, newer horizons.
Sen, D., Majumder, A., Arora, V., Yadu, N., & Chakrabarti, R. (2017) · PubMed Central · Cited by 7
Neuroprotection in Alzheimer’s Disease
Jain, K. K. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-049-2_8 · Cited by 7
Jian, Z., Wang, X., Tian, M., Liu, Y., Yao, H., Gong, L. Y., & Li, B. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4554271 · Cited by 6
Capturing the Alzheimer's disease pathological cascade
Tijms, B. M., & Visser, P. J. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30043-7 · Cited by 6
Kandiş, S., Altıntaş, L., Kızıldağ, S., Şimşek, F., ATEŞ, M., Alaçam, H., & Uysal, N. (2021) · Ankara Üniversitesi Veteriner Fakültesi Dergisi · doi:10.33988/auvfd.847817 · Cited by 6
Wong, F. C. C., Initiative, A. D. N., Saffari, S. E., Yatawara, C., Ng, K. P., & Kandiah, N. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210333 · Cited by 6
Lifespan brain activity, b-amyloid, and Alzheimer's disease
Jagust, W. J., & Mormino, E. C. (2011) · Cited by 6
Positron Emission Tomography in Alzheimer Disease
Schmidt, M. E., Matthews, D. C., Andrews, R. D., & Mosconi, L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-386945-6.00005-6 · Cited by 7
Lactate dehydrogenase inhibitors: A promising candidate against aging and fibrosis
Luo, W., Wang, G., Li, H., Guo, S., Zhao, C., Cao, Z., Pan, Z., Jiang, Z., Fan, H., Liu, L., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118377 · Cited by 5
Rabbani, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094584 · Cited by 7
Diabetes mellitus and Alzheimer's disease: Vacuolar adenosine triphosphatase as a potential link
Guo, B., Li, Q., Liu, X. M., Luo, G., Wu, Y., & Nie, J. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16286 · Cited by 5
Spotlight on aerobic glycolysis
Welberg, L. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2937 · Cited by 5
Dysfunctional gene splicing in glucose metabolism may contribute to Alzheimer's disease
Deng, S., Peng, Y., Xu, M., Yi, Q., & Feng, J. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002214 · Cited by 5
Patil, S. P., & Kuehn, B. R. (2024) · Pharmaceuticals · doi:10.3390/ph17040491 · Cited by 6
Neuroprotection in Alzheimer Disease
Jain, K. K. (2019) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-4939-9465-6_8 · Cited by 5
Glycolysis-enhancing α1-adrenergic antagonists are neuroprotective in Alzheimer’s diseasePreprint
Zhang, Q., Schultz, J. L., Simmering, J. E., Kirkpatrick, B. Q., Weber, M. A., Skuodas, S., Hicks, T. P., Pierce, G., Laughlin, M. H., Bertolli, A. X., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.03.647018 · Cited by 5
Vestergaard, M. B., Laursen, J. C., Heinrich, N. S., Rossing, P. R., Hansen, T. W., & Larsson, H. B. W. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1229509 · Cited by 4
Chrobak, A. A., Bielak, S., Nowaczek, D., Żyrkowska, A., Sobczak, A. M., Fąfrowicz, M., Bryll, A., Marek, T., Dudek, D., & Siwek, M. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1474313 · Cited by 4
Sharma, Y., Gupta, J. K., Babu, M. A., Singh, S., & Sindhu, R. K. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02269-5 · Cited by 6
Brain activity and Alzheimer’s disease: a complex relationship
Hansson, O., & Gouras, G. K. (2016) · Brain · doi:10.1093/brain/aww146 · Cited by 4
Meier, I. B., Lao, P. J., Gietl, A. F., Vorburger, R. S., Gutierrez, J., Holland, C. M., Guttmann, C. R. G., Meier, D., Buck, A., Nitsch, R. M., et al. (2020) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2020.100001 · Cited by 4
Mitochondrial control of microglial phagocytosis in Alzheimer’s diseasePreprint
Fairley, L. H., Lai, K. O., Wong, J. H., Salvatore, A. V., D’Agostino, G. A., Wu, X., Jayaraman, A., Langley, S. R., Ruedl, C., & Barron, A. M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.01.469111 · Cited by 4
Molecular and connectomic vulnerability shape cross-disorder cortical abnormalitiesPreprint
Hansen, J. Y., Shafiei, G., Vogel, J. W., Smart, K. A., Bearden, C. E., Hoogman, M., Franke, B., van Rooij, D., Buitelaar, J. K., McDonald, C. R., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.21.476409 · Cited by 4
Repurposing of Drugs: Updates and New Perspectives
Aher, P. R., Aher, R., Ahire, T., Patil, M. B., Shahare, H. V., & Gedam, S. S. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00723 · Cited by 3
Advances in non-human primate models for Alzheimer's disease research
Joho, D., Sato, K., Kumita, W., Saido, T. C., Sasaki, E., & Sasaguri, H. (2025) · Neuroscience Research · doi:10.1016/j.neures.2025.104984 · Cited by 6
Yao, M., Sun, N., Linville, R. M., Wei, Z., Kakazu, A., Ouyang, Y., Li, R., Du, L., Wang, H., Zhou, Y., et al. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00756-4 · Cited by 6
Glial lactate metabolism and transport in Alzheimer’s disease
Wang, Y., Feng, B., Hong, R., Qiu, D., Zhao, J., & Zhao, L. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1731089 · Cited by 3
Garrahy, J. P. (2025) · Journal of Alzheimer’s Disease · doi:10.1177/13872877251350338 · Cited by 6
Kahali, S., Kothapalli, S. V. V. N., Xu, X., Kamilov, U. S., & Yablonskiy, D. A. (2022) · NMR in Biomedicine · doi:10.1002/nbm.4883 · Cited by 3
Wang, F., Li, H., Kong, T., Shan, L., Guo, J., Wu, Y., Luο, X., Satyanarayanan, S. K., Su, K., & Liu, Y. (2024) · Brain and Behavior · doi:10.1002/brb3.3432 · Cited by 3
Cerebral lactate metabolism and memory: Implications for Alzheimer's disease
Harris, R. A. (2017) · Scholarship@Western (Western University) · Cited by 3
Tristão‐Pereira, C., Casquero‐Veiga, M., Malotaux, V., & Quiroz, Y. T. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261452181 · Cited by 3
Oh, H. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.900581 · Cited by 3
Lone, A., Khezaee, R., Kozlov, A. M., Courchesne, M. C. J., Nygard, K. L., Betts, D. H., & Cumming, R. C. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.10.007 · Cited by 3
Dang, A., Wang, D., Towne, J. M., Seshadri, S. S., Habes, M., & Fox, P. T. (2025) · Human Brain Mapping · doi:10.1002/hbm.70402 · Cited by 2
Hartz, S. M., Goswami, S., Oliver, A. I., Evans, A., Jackson, S., Linnenbringer, E. L., Moulder, K. L., Morris, J. C., & Mozersky, J. T. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-099970 · Cited by 5
Self-citationDavargaon, R. S., Verma, N., Kotiya, D., Leibold, N. S., Velmurugan, G. V., Ly, H., Chen, K. C., Ruíz, D., Corces, V. G., Liu, H., et al. (2026) · iScience · doi:10.1016/j.isci.2026.115157 · Cited by 2
Zaman, W., Ayaz, A., & Ullah, A. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118275 · Cited by 2
Kang, D. W., Lim, H. K., Jung, W. S., Jeong, J., Kim, T., Han, J., Lee, C. U., & Hong, S. (2015) · Sleep Medicine Research · doi:10.17241/smr.2015.6.1.1 · Cited by 2
Ahmad, W., & Shabbiri, K. (2025) · Journal of Molecular Medicine · doi:10.1007/s00109-025-02522-3 · Cited by 2
Pasquini, L., Tonch, A., Plant, C., Zherdin, A., Ortner, M., Kurz, A., Förstl, H., Zimmer, C., Grimmer, T., Wohlschäger, A., et al. (2014) · Brain Connectivity · doi:10.1089/brain.2013.0213 · Cited by 2
Tubi, M. A., Wheeler, K. V., Matsiyevskiy, E., Hapenney, M., Mack, W. J., Chui, H. C., King, K. S., Thompson, P. M., & Braskie, M. N. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.08.002 · Cited by 2
Protection against Aβ-induced neuronal damage by KU-32: PDHK1 inhibition as important target
Pal, R., Hui, D., Menchen, H., Zhao, H., Mozziconacci, O., Wilkins, H., Blagg, B. S. J., Schöneich, C., Swerdlow, R. H., Michaelis, M. L., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1282855 · Cited by 2
Ahmad, W. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/228429 · Cited by 2
Grizzanti, J., Moritz, W. R., Pait, M. C., Stanley, M., Kaye, S. D., Carroll, C. M., Constantino, N. J., Deitelzweig, L. J., Nicol, N. I., Snipes, J. A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.20.481215 · Cited by 2
Yao, M., Sun, N., Linville, R. M., Wei, Z., Kakazu, A., Ouyang, Y., Li, R., Du, L., Wang, H., Zhou, Y., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.23.650260 · Cited by 2
Dagher, A., & Mišić, B. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.015 · Cited by 1
Liu, Y., Sundman, M., Hinderaker, D., Chen, A. Y.-C., Green, J. M., Haaheim, L. G., Siu, H. M., Jezerc, C., Lai, K., Chen, C. C. L., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1592678 · Cited by 1
Ali, S., Ayaz, A., & Zaman, W. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118343 · Cited by 1
Kang, D. W., Lim, H. K., Jung, W. S., Jeong, J., Kim, T., Han, J., Lee, C. U., & Hong, S. (2015) · Cited by 1
Brain Blood Flow and Metabolism: Variable Relationships in Altered Metabolic States
Blazey, T. (2019) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/0fg3-0s34 · Cited by 1
Neuroimaging Advances in Alzheimer's Disease
Schonhaut, D. R., & Rabinovici, G. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00017-2 · Cited by 1
Roh, J. H., & Holtzman, D. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809813-4.00007-7 · Cited by 1
A Human Neuroimaging Perspective on Sleep in Normative and Pathological Ageing
Cross, N. E., Gosselin, N., & Dang‐Vu, T. T. (2019) · Current Sleep Medicine Reports · doi:10.1007/s40675-019-0133-z · Cited by 1
„Default-mode“-Netzwerk des Gehirns. Neurobiologie und klinische Bedeutung
Otti, A., Gündel, H., Wohlschläger, A., Zimmer, C., Sorg, C., & Noll‐Hussong, M. (2012) · Der Nervenarzt · Cited by 1
The Role of Apolipoprotein E Concentration and Isoform in Amyloid-beta Metabolism In Vivo
Castellano, J. M. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7416v3s
Mechanisms of Brain Region-Specific Amyloid-beta Deposition
Bero, A. W. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7cj8bh2
Simmons, C. R. (2011) · UKnowledge (University of Kentucky)
Caffeolyquinic Acid Induces the Upregulation of Glycolytic Enzymes
Han, J., Sasaki, K., Omri, A. E., & Isoda, H. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-409517-5.00099-1
Alzheimer's disease: sleep, neuronal activation and the default mode network
Krajnc, A. M. (2012) · Utrecht University Repository (Utrecht University)
Absolute quantification of oxygen metabolism in the human brain using FMRI
Stone, A. J. (2014) · ORCA Online Research @Cardiff (Cardiff University)
Degradation of Mnemonic Networks in Aging and Alzheimer’s Disease
Chhatwal, J. P. (2015) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Alzheimer’s Disease and the Sleep–Wake Cycle
Bero, A. W., & Tsai, L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802851-3.00010-3
Chandrasekaran, S. (2013) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Zhao, Y. (2017) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7f47mkc
Singh, O. (2017) · Scholarship@Western (Western University)
Metabolic study of Alzheimer’s disease using mutant C. elegans
Ahmad, W. (2017) · The University of Queensland · doi:10.14264/uql.2017.500
Fact, Fiction, or Evolution: Mechanism Hypothesis of Alzheimer’s Disease
Pardo, J. V. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.83824
Molecular Marker and Therapeutic Regimen for Neurodegenerative Diseases
Dey, S., Rai, N., Shekhar, S., Singh, A. P., & Agnihotri, V. (2019) · Springer eBooks · doi:10.1007/978-981-13-3585-3_2
Microglial Mitophagy and Neurodegenerative Disorders
Oyindamola, E. A., Agyemang, M. K., Owusu-Sarfo, J., Yeboah, K. O., & Osafo, N. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-1317-0.ch004
Yablonskiy, D. A., Benzinger, T. L. S., & Morris, J. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00032-3
Self-citationAmyloid beta resistance and the Warburg effect: Re-examining Alzheimer's disease
Newington, J. T. (2013) · Scholarship@Western (Western University)
Insulin gene expression and functional activity of insulin signaling pathway in Alzheimer's disease
Gorina, Y. V., Хилажева, Е. Д., Komleva, Y. K., Lopatina, O. L., & Salmina, A. B. (2021) · Fundamental and Clinical Medicine · doi:10.23946/2500-0764-2021-6-4-8-21
Oh, H. (2022) · bioRxiv · doi:10.1101/2022.01.23.477394 · Cited by 2
Gorina, Y. V., Хилажева, Е. Д., Mosiagina, A. I., Kharitonova, E. V., Рафаилевна, К. М., Stelmashook, E. V., Исаев, Н. К., Rozanova, N. A., & Salmina, A. B. (2022) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093022030218
Lowering glucose enhances BACE1 activity and Aβ generation in mouse brain slice culturesPreprint
Sheppard, O., Humphrey, R., Durrant, C. S., & Coleman, M. P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.12.584616
Visser, P. J., Reus, L. M., Gobom, J., Jansen, I. E., Dicks, E., van der Lee, S. J., Tsolaki, M., Verhey, F. R. J., Popp, J., Martínez‐Lage, P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19445890
Lucas-Clarke, H. J., Maddison, D. C., Amadio, L., Buhl, E., O’Hare, K., Regnault, C., Peters, O. M., Hodge, J. J. L., & Smith, G. A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.01.651195
Genetic regulators of neuronal survival across metabolic environmentsPreprint
Bennett, N. K., Soto-Muniz, Y., Meng, J. X., Lee, M., Yang, J. L., Flanigan, W., Pico, A. R., Jain, I. H., & Nakamura, K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.19.695350
Farmer, B. C., Williams, H. C., Devanney, N. A., Piron, M. A., Nation, G. K., Carter, D. J., Walsh, A. E., Khanal, R., Young, L. E. A., Kluemper, J. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16575414
Visser, P. J., Reus, L. M., Gobom, J., Jansen, I. E., Dicks, E., van der Lee, S. J., Tsolaki, M., Verhey, F. R. J., Popp, J., Martinez-Lage, P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19445893
Shinohara, M., Gheni, G., Kawai, K., Morishima, M., Murayama, S., Saito, Y., Bu, G., & Sato, N. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02146-1
Metabolic Coherence of the Mouse BrainPreprint
Liu, Z., Ma, X., Ribas, R. A., Medina, T., Quiñones, S., Son, J., Wu, L., Ryan, A. M., Shedlock, C. J., Ziani, B., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.07.723592
Age-related changes to brain energetics revealed by PET/MRI imaging
Bevington, C. W. J., Dhaliwal, S., McKenzie, J., Stoessl, A. J., & Sossi, V. (2026) · NeuroImage Clinical · doi:10.1016/j.nicl.2026.104014
Jangra, J., Mahindru, I., & Kumar, R. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.05.005
Kawabe, N., Hosoki, S., Watanabe, C., Maekawa, K., Fukushima, H., Matsuishi, K., IWATA, K., Kohara, N., & Kawamoto, M. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261462928
Non‐Alzheimer Aβ deposits in the human CNS : Implications with hypoxia and related conditions
Karlovich, E., Priemer, D. S., Rhodes, C. H., Perl, D. P., Tanji, K., & Goldman, J. E. (2026) · Brain Pathology · doi:10.1111/bpa.70120
Glycolysis-enhancing α1-adrenergic antagonists have therapeutic potential in Alzheimer’s disease
Zhang, Q., Schultz, J. L., Simmering, J. E., Kirkpatrick, B. Q., Weber, M. A., Skuodas, S., Hicks, T., Pierce, G., Laughlin, M., George, B., et al. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02135-z · Cited by 5
Astrocytic lactate shuttle disruption and the energy-starved lysosome in Alzheimer's diseasePreprint
Kim¹, Y., Heo, W., Park, S. J., Kim, Y., & Cho², Y. E. (2026) · Research Square · doi:10.21203/rs.3.rs-10057949/v1
Vasilkovska, T., Page, L. M. L., Guglielmetti, C., Radoul, M., Li, H., Xiao, J. N., Gordon, J. W., Nakamura, K., & Chaumeil, M. M. (2026) · Research Square · doi:10.21203/rs.3.rs-10437814/v1
Hu, X., Yu, Y., Luo, H., Li, J., Zhang, X., Wang, G., Li, J., Li, J., Chen, H., & Qiu, Y. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00567-z
Metadata
- Authors
- Vlassenko, A. G., Vaishnavi, S. N., Couture, L., Sacco, D., Shannon, B. J., Mach, R. H., Morris, J. C., Raichle, M. E., & Mintun, M. A.
- Affiliations
- Washington University in St. Louis (US)
- Departments of aRadiology,
- Neurology,
- Corresponding author
- Mintun, Mark A.
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-09-13
- Volume
- 107
- Issue
- 41
- Pages
- 17763-17767
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2955133
- OpenAlex
- W2137243283
- Cited by
- 404
- References
- 84
- Citations by year
- 2026: 20 · 2025: 21 · 2024: 15 · 2023: 21 · 2022: 26 · 2021: 22 · 2020: 24 · 2019: 20 · 2018: 28 · 2017: 41 · 2016: 20 · 2015: 23 · 2014: 28 · 2013: 33 · 2012: 28
- FWCI
- 20.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p20mh077967-04, AG05681, AG003991)
- National Institute on Aging (P50AG005681, P01AG003991)
- National Institute of Mental Health (P20MH-077967)
- National Institute of Neurological Disorders and Stroke (F30NS057901, P30NS048056, P50NS006833)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- aerobic glycolysis, amyloid-beta deposition, Alzheimer's disease, default mode network, brain glucose metabolism, oxidative phosphorylation, spatial correlation, young adults, positron emission tomography
- MeSH terms
- Adult, Alzheimer Disease, Amyloid, Brain, Female, Glucose, Glycolysis, Humans, Male, Oxygen, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
